Not long after Novo Nordisk received an untitled letter from the FDA disputing certain elements of the first TV spot for its ...
This time, the FDA took issue with how the ad positioned Ozempic as superior to other GLP-1s, taking aim at small details from comedic devices to the color of shirts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results